BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17595285)

  • 21. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
    Butorac-Petanjek B; Parnham MJ; Popovic-Grle S
    J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of rhinosinusitis in the outpatient setting.
    Poole MD; Portugal LG
    Am J Med; 2005 Jul; 118 Suppl 7A():45S-50S. PubMed ID: 15993677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
    Lode H; Eller J; Linnhoff A; Ioanas M;
    Eur Respir J; 2004 Dec; 24(6):947-53. PubMed ID: 15572537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics.
    Kuriyama T; Williams DW; Yanagisawa M; Iwahara K; Shimizu C; Nakagawa K; Yamamoto E; Karasawa T
    Oral Microbiol Immunol; 2007 Aug; 22(4):285-8. PubMed ID: 17600542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
    Martinez FJ; Anzueto A
    Am J Med; 2005 Jul; 118 Suppl 7A():39S-44S. PubMed ID: 15993676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and outcome of severe chronic obstructive pulmonary disease exacerbations caused by multidrug-resistant bacteria.
    Nseir S; Ader F
    Curr Opin Pulm Med; 2008 Mar; 14(2):95-100. PubMed ID: 18303416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China.
    Ye F; He LX; Cai BQ; Wen FQ; Chen BY; Hadiarto M; Chen RC; Yuan JP; Sun HL
    Chin Med J (Engl); 2013 Jun; 126(12):2207-14. PubMed ID: 23786927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bacterial pathogens in sputum and degree of bronchial obstruction in patients with acute exacerbation of chronic obstructive pulmonary disease].
    Biagini M; Rossi M
    Recenti Prog Med; 2002 Sep; 93(9):470-3. PubMed ID: 12355983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe acute exacerbation of chronic obstructive pulmonary disease: when are multiple-drug-resistant bacteria the culprits?
    Epstein SK
    Crit Care Med; 2006 Dec; 34(12):3047-8. PubMed ID: 17130702
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clarythromycin in the treatment of exacerbations of chronic obstructive lung disease].
    Shmelev EI; Ergeshev AE; Shmeleva NM; Sidorova VP
    Probl Tuberk Bolezn Legk; 2006; (8):42-7. PubMed ID: 17002058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prediction model for bacterial etiology in acute exacerbations of COPD.
    Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
    Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage.
    Di Marco F; Braido F; Santus P; Scichilone N; Blasi F
    Eur Rev Med Pharmacol Sci; 2014; 18(3):321-32. PubMed ID: 24563430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong.
    Ko FW; Ng TK; Li TS; Fok JP; Chan MC; Wu AK; Hui DS
    Respir Med; 2005 Apr; 99(4):454-60. PubMed ID: 15763452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive ventilation: comparison of effectiveness, safety, and management in acute heart failure syndromes and acute exacerbations of chronic obstructive pulmonary disease.
    Pladeck T; Hader C; Von Orde A; Rasche K; Wiechmann HW
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):539-49. PubMed ID: 18204168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease].
    Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (12):13-6. PubMed ID: 15719658
    [No Abstract]   [Full Text] [Related]  

  • 36. [Routine use of extended-release clarithromycin tablets for short-course treatment of acute exacerbations of non-severe COPD].
    LĂ©ophonte P; Zuck P; Perronne C; Baconnet B
    Med Mal Infect; 2008 Sep; 38(9):471-6. PubMed ID: 18722065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National study of emergency department visits for acute exacerbation of chronic obstructive pulmonary disease, 1993-2005.
    Tsai CL; Sobrino JA; Camargo CA
    Acad Emerg Med; 2008 Dec; 15(12):1275-83. PubMed ID: 18976335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)].
    Burgel PR
    Med Mal Infect; 2006; 36(11-12):706-17. PubMed ID: 16839731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
    Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
    Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.